Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. - sprookjes - yvandenbroek - TriplyDB

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

http://www.wikidata.org/entity/Q40247465

about

Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.DNA vaccines: developing new strategies against cancer.beta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge CD4+ T cell-independent DNA vaccination against opportunistic infections.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection Designing the optimal vaccine: the importance of cytokines and dendritic cells.Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.Reduced tumourigenicity of EG7 after RANTES gene transfer and the underlying mechanism.CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.Developing DNA vaccines that call to dendritic cells.Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene.The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines.Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies.Cancer genome sequencing and its implications for personalized cancer vaccines.Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency DNA vaccines for targeting bacterial infections.Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation.DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNA Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.

P2860

Q27472925-A3AC29D9-AF14-4A90-BDCA-D0E22CFEEABA Q28484629-927BFF26-CC51-4F3D-9265-152EBB2CE1AA Q33698112-30AB380A-06F0-4E1E-8B14-5372DB0B00DA Q33756622-1447067F-A60C-4EDA-95E7-77A22E7BFCAA Q33960217-DC639080-D27C-40E6-867C-BEDA85650298 Q34059531-6D9B3E0C-0875-49E0-8C4D-E2FB7CD5F0E7 Q34147169-73E663D3-4EA4-4848-A2A0-32BC30598CD9 Q34309830-450E1FBA-3131-4643-8024-1C3B9D099CAD Q34717036-97644494-89BC-42FE-802C-83C46B3C089E Q35083138-96C8CD17-55D1-4EAA-900E-DAF9E12CBEC9 Q35146556-AD756A3E-E79D-4A62-8C69-76DFD18D9743 Q35185997-50F7F929-8A0D-44DF-B77E-C060640AB2CB Q35413374-B3E46109-F717-4EC9-9D87-D889E79B90A2 Q35827348-5A2012E6-AD19-40CC-B8E2-975ED3BEC9D4 Q35854792-BA3BE386-0E5F-4591-954D-02F56730F495 Q35936512-45543E3C-6BA2-400D-B2B1-0C0B063860B3 Q35946021-61779F1F-BF31-4C72-B4D4-5420EAEE89CF Q36220691-3887DAF7-CC07-4605-ACC5-22DC6E8B18BC Q36305188-B45124E4-058E-40A1-8AE5-4A8D349AB51F Q36489528-378293A8-73CC-4E70-AA51-1CDE81E9A8B0 Q36627931-9E32A9D2-CF64-4AB8-92A0-544C391C762A Q36780146-6DD64813-BDFC-4156-ABA0-9ADF678B278B Q37010987-6F82F057-FB07-4934-9E70-3D264443413F Q37148184-27F3DAF3-1EDA-4613-A4E5-101D0FA82E34 Q37277900-47BD677A-6E37-4542-983E-D06F18838A55 Q37333924-0033567D-E1DD-4B39-8F50-6212C960765A Q37388709-19BF1C22-721C-45AA-93C2-B2F58DFD01A6 Q37507487-E1BF1802-5C5B-42CE-B42B-89AF1562A52F Q37771943-4B2B0E2E-0D31-4836-8134-C7FA376254B6 Q38610641-D7512EFF-208E-44BC-9E1C-A473C0186BBC Q39509643-7452F467-8E27-48A2-9797-C119ADE5BAA6 Q39797438-2D9DD946-AF5C-40F1-AB78-43293BB9A39C Q40333540-9471A133-8567-4FD4-832D-5ED47DF20AC5

P2860

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

http://www.wikidata.org/entity/Q40247465

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Recruitment and expansion of d ...... icity of plasmid DNA vaccines.

@en

type

label

Recruitment and expansion of d ...... icity of plasmid DNA vaccines.

@en

prefLabel

Recruitment and expansion of d ...... icity of plasmid DNA vaccines.

@en

P1433

Q40247465-453BB1F3-AAA5-4909-AF69-493F0B60EF97

P1476

Q40247465-90021B07-0CB2-446A-B993-E80F00004F94

P2093

Q40247465-2C53AF2D-2540-44EA-8C96-7721E5DBA69D

Q40247465-352C3B48-41EB-49B7-86FF-F6F3E936A967

Q40247465-45009E53-87F8-4116-B48F-FBBE10AAD8DB

Q40247465-4B53A1E5-59B2-4EB5-A67B-23A1FE723B35

Q40247465-80DB3E21-1500-4FD4-9B22-818ACCCCDEB5

Q40247465-BD019863-C00F-4207-AC45-8DDB452F4007

Q40247465-CE6AADAC-230B-4290-9A49-C9042CC83DA8

Q40247465-D44C27FA-1428-4649-A38A-E1E63385D867

Q40247465-DD5E5652-BFD4-4672-8D2A-85CDA205CB13

P2860

Q40247465-108F295D-A9D6-4244-B1AD-3D23CE0516ED

Q40247465-1E1C12A0-7C95-4A24-899A-9CD578EA92FE

Q40247465-1E7A6A71-3B8E-4AF5-AB51-8E6104271A48

Q40247465-2F8B3796-286B-417B-90BE-59DCFACC3229

Q40247465-302F4B0D-DF19-4C06-A1B3-C03A07DBAA84

Q40247465-306BF5D9-62CC-432C-99FC-0E0E6E715B04

Q40247465-35EC1107-C650-40B4-A6B1-6E694DCDAFD4

Q40247465-4593C068-6175-423D-8E1D-FBB0D27118C1

Q40247465-534ADC8F-2C8A-49DC-B044-D8104670C6A4

Q40247465-553E4B1D-30D5-434B-A643-4917A62A03FB

P304

Q40247465-69436AF0-6A52-4C08-AFCF-E204740BD0C9

P31

Q40247465-F6865B32-541F-4204-B02D-F92D252EDFA9

P356

Q40247465-6480197B-5EF0-49F7-A1FA-023323513B82

Q40247465-E168D367-559F-4263-B247-81EB0C8EC7B1

P407

Q40247465-AAC091C1-E47C-4E26-8E2F-978CD3DBEEE4

P433

Q40247465-3979171C-3FC5-4CA9-B20C-73BFEE632CB5

P478

Q40247465-F4F138E9-EE37-4FAA-9FCC-8A2694771B6C

P50

Q40247465-6651EE02-67AB-4818-A6C3-F03F779AFF97

Q40247465-8859BB1D-308F-4DDD-9A8D-FCBC439E0AFB

P577

Q40247465-92FD5D8E-D9FE-4695-BB43-99D3A0F2B406

P5875

Q40247465-BE005465-CD5A-4127-BDEA-2268E7EC5585

P698

Q40247465-39A9CFD1-90EE-4944-B302-7195D5E15027

P932

Q40247465-00DB3553-4E11-431C-8F7D-2EF7D1CC973B

P356

P1433

Journal of Clinical Investigation

P1476

Recruitment and expansion of d ...... nicity of plasmid DNA vaccines

@en

P2093

Dan H Barouch

http://www.w3.org/2001/XMLSchema#string

Darci A Gorgone

http://www.w3.org/2001/XMLSchema#string

Diana M Truitt

http://www.w3.org/2001/XMLSchema#string

Michael G Kishko

http://www.w3.org/2001/XMLSchema#string

Michael S Seaman

http://www.w3.org/2001/XMLSchema#string

Michelle A Lifton

http://www.w3.org/2001/XMLSchema#string

Norman L Letvin

http://www.w3.org/2001/XMLSchema#string

Shawn M Sumida

http://www.w3.org/2001/XMLSchema#string

Shawn S Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

Dendritic cells and the control of immunity

Phenotypic analysis of antigen-specific T lymphocytes

Dendritic cells: specialized and regulated antigen processing machines

Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant.

DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo

Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines.

Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations.

Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.

C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis

P304

1334-1342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200422608

http://www.w3.org/2001/XMLSchema#string

10.1172/JCI22608

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Janelle C Arthur

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8199391

http://www.w3.org/2001/XMLSchema#string

P698

15520866

http://www.w3.org/2001/XMLSchema#string

P932

524232

http://www.w3.org/2001/XMLSchema#string